Last update 08 May 2025

Nucleoside-modified TERT mRNA (Rejuvenation Technologies)

Overview

Basic Info

Drug Type
mRNA
Synonyms
nucleoside-modified TERT mRNA (Rejuvenation Technologies)
Target
TERT x Telomerase
Action
modulators, activators
Mechanism
TERT modulators(Telomerase reverse transcriptase modulators), Telomerase activators(Telomerase activators)
Therapeutic Areas
Digestive System DisordersHemic and Lymphatic DiseasesRespiratory Diseases
Active Indication
Bone Marrow Failure DisordersCompensated cirrhosisCytopenia+ [2]
Inactive Indication-
Originator Organization
Stanford UniversityStanford University
Active Organization
Rejuvenation Technologies, Inc.Rejuvenation Technologies, Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with Nucleoside-modified TERT mRNA (Rejuvenation Technologies)
Login to view more data
100 Translational Medicine associated with Nucleoside-modified TERT mRNA (Rejuvenation Technologies)
Login to view more data
100 Patents (Medical) associated with Nucleoside-modified TERT mRNA (Rejuvenation Technologies)
Login to view more data
100 Deals associated with Nucleoside-modified TERT mRNA (Rejuvenation Technologies)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Bone Marrow Failure DisordersPreclinical
United States
Rejuvenation Technologies, Inc.Rejuvenation Technologies, Inc.
15 Apr 2024
Compensated cirrhosisPreclinical
United States
Rejuvenation Technologies, Inc.Rejuvenation Technologies, Inc.
15 Apr 2024
CytopeniaPreclinical
United States
Rejuvenation Technologies, Inc.Rejuvenation Technologies, Inc.
15 Apr 2024
Decompensated cirrhosis of liverPreclinical
United States
Rejuvenation Technologies, Inc.Rejuvenation Technologies, Inc.
15 Apr 2024
Pulmonary Disease, Chronic ObstructivePreclinical
United States
Rejuvenation Technologies, Inc.Rejuvenation Technologies, Inc.
15 Apr 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free